MedTrace Logo

Whey Protein Effect on Glycaemic and Appetite Responses in T2D

NCT02903199 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2016-09-16

No results posted yet for this study

Summary

The current study will investigate the effect if whey protein on postprandial glycaemia and appetite in type II diabetics, assessing incretin (GLP-1, GIP), insulin, and appetite control (leptin, PYY3-36) hormone responses.

Conditions

Interventions

DIETARY_SUPPLEMENT

Whey Protein

Whey protein (18 g) administered immediately prior to breakfast and lunch meals.

DIETARY_SUPPLEMENT

Hydrolysed Protein

Hydrolysed whey protein (19.1 g) administered immediately prior to breakfast and lunch meals.

DIETARY_SUPPLEMENT

Placebo

Placebo intervention administered immediately prior to breakfast and lunch meals.

Sponsors & Collaborators

  • Northumbria University

    lead OTHER

Principal Investigators

  • Mark Walker · Newcastle University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2016-02-29
Completion
2016-10-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02903199 on ClinicalTrials.gov